Helena Cowley

Helena Cowley has over a decade of experience in roles of increasing responsibility in biotech. Prior to Oxidien, Helena was CEO of Captozyme, Inc., a contract manufacturing organization she built, alongside the two scientific co-founders, and then spearheaded the exit of to Arranta Bio in 2019. Over Helena’s tenure, Captozyme tripled revenues and was named among the top 50 fastest-growing University of Florida alumni-led businesses in the 2019 Gator100 and a “Florida Company to Watch” in 2017. Helena is a co-inventor on two patents and received the Florida Governor’s Entrepreneur Award in 2015.